Romark’s investigational Covid-19 drug lowers disease progression in trial
15 Apr 2021 //
CLINICALTRIALSARENA
Lupin launches generic diarrhea drug in US market
09 Mar 2021 //
INDIATIMES
FDA Approves Romark Facility in Puerto Rico
24 Aug 2020 //
CONTRACTPHARMA
How Orphan Drug Policy Could Impede Access To COVID-19 Treatments
25 Jun 2020 //
RAPS
Predicting the dose for repurposing nitazoxanide in COVID-19
07 May 2020 //
NEWSMEDICAL
Romark Initiates Phase 3 Clinical Trials Of NT-300 For COVID-19
27 Apr 2020 //
PR NEWSWIRE
Romark Initiates Phase 3 Clinical Trials Of NT-300 For COVID-19
27 Apr 2020 //
PR NEWSWIRE
Can old drugs take down a new coronavirus?
13 Mar 2020 //
C&EN